Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics
Authors:
- 6 February 2025
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (3) , 435-441
Abstract
No abstract availableKeywords
Funding Information
- NIHR Leeds Musculoskeletal Biomedical Research Unit
- European Union
This publication has 25 references indexed in Scilit:
- Risk of developing inflammatory arthritis in patients with psoriasis initiating treatment with biologics: A population-based analysisJournal of the American Academy of Dermatology, 2024
- Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-AnalysisRheumatology and Therapy, 2021
- Incidence of Psoriatic Arthritis Among Patients Receiving Biologic Treatments for Psoriasis: A Nested Case–Control StudyArthritis & Rheumatology, 2021
- Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational studiesJournal of the American Academy of Dermatology, 2021
- Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 StudyJournal of Investigative Dermatology, 2019
- Enthesitis: A hallmark of psoriatic arthritisSeminars in Arthritis and Rheumatism, 2018
- The pathogenesis of psoriatic arthritisThe Lancet, 2018
- The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort StudyArthritis & Rheumatology, 2015
- A tutorial on propensity score estimation for multiple treatments using generalized boosted modelsStatistics in Medicine, 2013
- Classification criteria for psoriatic arthritis: Development of new criteria from a large international studyArthritis & Rheumatism, 2006